Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adaptimmune Ther ADR (ADAP)

Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adaptimmune Ther ADR 60 JUBILEE AVENUE MILTON PARK ABINGDON X0 OX14 4RX GBR

www.adaptimmune.com Employees: 449 P: 44-12-3543-0000 F: 123-543-0001

Description:

Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 154,784
Enterprise Value, $K 10,794
Shares Outstanding, K 255,883
Annual Sales, $ 60,280 K
Annual Net Income, $ -113,870 K
Last Quarter Sales, $ 40,900 K
Last Quarter Net Income, $ -17,620 K
EBIT, $ -45,100 K
EBITDA, $ -35,260 K
60-Month Beta 2.18
% of Insider Shareholders 12.44%
% of Institutional Shareholders 31.37%
Float, K 224,051
% Float 87.56%
Short Volume Ratio 0.11

Growth:

1-Year Return 37.07%
3-Year Return -85.28%
5-Year Return -56.17%
5-Year Revenue Growth 1.29%
5-Year Earnings Growth 34.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm -0.22
EPS Growth vs. Prev Qtr -125.93%
EPS Growth vs. Prev Year 65.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ADAP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -74.15%
Return-on-Assets % -15.09%
Profit Margin % -188.90%
Debt/Equity 0.62
Price/Sales 2.55
Price/Cash Flow N/A
Price/Book 1.92
Book Value/Share 0.31
Interest Coverage -0.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar